BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36682351)

  • 1. Impact of the COVID-19 Pandemic on Cervical Cancer Screening in São Paulo State, Brazil.
    Martins TR; Witkin SS; Mendes-Corrêa MC; Godoy AS; Cury L; Balancin ML; Ab'Saber AM; Peres SV; Messias S; Tozetto Mendoza TR; Longatto-Filho A
    Acta Cytol; 2023; 67(4):388-394. PubMed ID: 36682351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Analyses of the Introduction of Liquid-Based Cytology in a Public Health Service of the State of São Paulo, Brazil.
    Longatto-Filho A; Levi JE; Martins TR; Cohen D; Cury L; Villa LL; Eluf-Neto J
    Acta Cytol; 2015; 59(3):273-7. PubMed ID: 26279162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) infections as risk factors for cytological and histological abnormalities in baseline PAP smear-negative women followed-up for 2 years in the LAMS study.
    Gontijo RC; Derchain SF; Roteli-Martins C; Bragança JF; Sarian LO; Morais SS; Maeda MY; Longatto-Filho A; Syrjänen KJ
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):239-46. PubMed ID: 16814450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 in Cervical and Breast Cancer Screening and Systemic Treatment in São Paulo, Brazil: An Interrupted Time Series Analysis.
    Duarte MBO; Argenton JLP; Carvalheira JBC
    JCO Glob Oncol; 2022 Jun; 8():e2100371. PubMed ID: 35696624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organized Cervical Cancer Screening Program in Barretos, Brazil: Experience in 18 Municipalities of São Paulo State.
    Possati-Resende JC; Vazquez FL; Biot ST; Mauad EC; Talarico T; Fregnani JHTG; Longatto-Filho A
    Acta Cytol; 2018; 62(1):19-27. PubMed ID: 29069645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
    Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
    Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
    Liao SY; Stanbridge EJ
    Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study.
    Syrjänen K; Naud P; Derchain S; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Hammes LS; Matos J; Gontijo R; Sarian L; Braganca J; Arlindo FC; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S
    Anticancer Res; 2005; 25(5):3469-80. PubMed ID: 16101165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening in Teresina, Piauí, Brazil: evaluation study using data of the Cervical Cancer Information System, 2006-2013.
    Damacena AM; Luz LL; Mattos IE
    Epidemiol Serv Saude; 2017; 26(1):71-80. PubMed ID: 28226009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
    Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
    Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Guo M; Khanna A; Wang J; Dawlett MA; Kologinczak TL; Lyons GR; Bassett RL; Sneige N; Gong Y; Bevers TB
    Cancer Cytopathol; 2017 Aug; 125(8):644-651. PubMed ID: 28498639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of pap smears and immunocytochemical detection of the p16 and Ki67 proteins in women with cervical intraepithelial neoplasia and cervical cancer].
    Rokita W; Skawiński D; Zmelonek-Znamirowska A; Kedzia W; Karowicz-Bilińska A; Spaczyński R; Spaczyński M
    Ginekol Pol; 2012 Nov; 83(11):822-6. PubMed ID: 23379189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical intraepithelial neoplasia in adolescents: study of cytological findings between 1987 and 1995 in São Paulo State-Brazil.
    Utagawa ML; Pereira SM; Cavaliere MJ; Maeda MY; Shih LW; Shirata NK
    Arch Gynecol Obstet; 1998; 262(1-2):59-64. PubMed ID: 9836001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of cervical intraepithelial neoplasia and invasive carcinoma based on cytological screening in the region of Campinas, São Paulo, Brazil.
    d'Ottaviano-Morelli MG; Zeferino L; Cecatti JG; Terrabuio DR; Martinez EZ
    Cad Saude Publica; 2004; 20(1):153-9. PubMed ID: 15029316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
    N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Previous screening for cervical cancer among women with cytological and histological abnormalities].
    Rama C; Roteli-Martins C; Derchain S; Longatto-Filho A; Gontijo R; Sarian L; Syrjanen K; Ching T; Aldrighi J
    Rev Saude Publica; 2008 Jun; 42(3):411-9. PubMed ID: 18470363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Risk HPV Testing in Primary Screening for Cervical Cancer in the Public Health System, São Paulo, Brazil.
    Levi JE; Martins TR; Longatto-Filho A; Cohen DD; Cury L; Fuza LM; Villa LL; Eluf-Neto J
    Cancer Prev Res (Phila); 2019 Aug; 12(8):539-546. PubMed ID: 31189569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 1,030,482 Cervical Smear Results in Brazilian Population.
    Campaner AB; Fernandes GL
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):867-872. PubMed ID: 36974539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
    Tiews S; Steinberg W; Schneider W; Hanrath C
    J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.